merck & co. inc.
(6MK:German Stock Exchange)
Transactions by MERCK & CO. INC. (6MK) in the last 6 months
Arvinas, Inc. announced that it will receive funding from new investor Merck & Co., Inc. on April 7, 2015. The terms of the transaction were not disclosed.
Merck & Co. Inc. (NYSE:MRK) announces a share repurchase program. Under the program, the company will repurchase up to $10,000 million worth of common stock. The repurchases will be made over time in open-market transactions, block transactions on or off an exchange, or in privately negotiated transactions. The shares will be repurchased for its treasury. The program reinforces company's commitment to deliver increased value to the shareholders and the Board's confidence ...
NGM Biopharmaceuticals, Inc. announced that it will receive $106 million from new investor Merck & Co. Inc. on February 23, 2015. The investor will acquire 15% stake in the company. The round will be raised at a post-money valuation of $706 million. The funding raised will represent 20% premium to NGM’s most recent financing. The company has issued convertible series E preferred stock Pursuant to Regulation D.
|3M Co||$151.11 USD||+2.40|
|Amgen Inc||$172.74 USD||+7.20|
|Bayer AG||€131.00 EUR||+3.66|
|Gilead Sciences Inc||$113.07 USD||+2.53|
|GlaxoSmithKline PLC||1,329 GBp||-4.50|
|View Industry Companies|